Abbott Rapid Dx N America LLC Reproductive Endocrinology Control Set McKesson Consult" Pregnancy ...

FDA Device Recall #Z-1312-2024 — Class II — January 9, 2024

Recall Summary

Recall Number Z-1312-2024
Classification Class II — Moderate risk
Date Initiated January 9, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Mckesson Medical-Surgical Inc. Corporate Office
Location Richmond, VA
Product Type Devices
Quantity 3 units

Product Description

Abbott Rapid Dx N America LLC Reproductive Endocrinology Control Set McKesson Consult" Pregnancy (hCG) Testing Positive Level / Negative Level 2 X 4 mL

Reason for Recall

Facility Critical Temperature Excursions on 08-JAN 2024 in Walk-In refrigerator due to mechanical failures, causing temperatures to fall below the validated range of 35.6 - 46.4 Degrees Fahrenheit (2 - 8 Degrees Celsius) for up to 60 minutes which could increase the probability of an incorrect test result or a delayed test result.

Distribution Pattern

US Nationwide distribution in the states of AZ, PA and TX.

Lot / Code Information

Catalogue Number: 5011; UDI/DI: 612479202788; Lot No. KN00589;

Other Recalls from Mckesson Medical-Surgical Inc. Corpor...

Recall # Classification Product Date
Z-2337-2025 Class II Clearview Strep A Exact II Dipstick Respiratory... Jul 30, 2025
Z-1842-2025 Class II ABBOTT DIAGNOSTICS ARCH AUSAB ANTI-HBS (100/EA)... Apr 24, 2025
Z-1837-2025 Class II ORTHO CLINICAL DIAGNOSTICS INC VITROS BUN (60/C... Apr 24, 2025
Z-1854-2025 Class II SEKISUI DIAGNOSTICS LLC SERUM HCG OSOMGENZME CO... Apr 24, 2025
Z-1846-2025 Class II ABBOTT POINT OF CARE TEST CREA I-STAT (25/BX) A... Apr 24, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.